Science

Feb 8, 2025, 06:51

Emre Yekedüz: A new era has started in the treatment of kidney cancer

Emre Yekedüz, Associate Professor of Medical Oncology at Ankara University, shared an article by David A. Braun, et al. on X:

“A new era has just started in the treatment of kidney cancer!

This masterpiece study put novel insights on RCC treatment!

A Phase I trial of a personalized cancer vaccine in high-risk RCC shows no recurrences in 9 patients, strong T-cell responses against driver mutations (VHL, PBRM1, BAP1, etc.), and durable immune activation.”‘

A neoantigen vaccine generates antitumour immunity in renal cell carcinoma.

Authors: David A. Braun, et al.

Emre Yekedüz: A new era has started in the treatment of kidney cancer

Ankara University cancer David A. Braun Emre Yekedüz fight against cancer Global fight against cancer kidney cancer MedOnc neoantigen vaccine OncoDaily Oncology RCC renal cell carcinoma

Oncologist Near Me – Fedro Alessandro Peccatori: Leading Expert in Gynecological Oncology

MATTERHORN trial - FLOT plus durvalumab will become the new standard of care in the preoperative setting for gastroesophageal cancer

Daiichi Sankyo's and Astrazeneca's press release on ENHERTU®: Latest Updates from DESTINY-Gastric04 trial

13-year-old Cancer Survivor Sworn in as a Secret Service agent by President Trump - The White House

The European Parliament Intergroup on Cancer and Rare Diseases has been set in motion - ECO